annual cash & cash equivalents:
$1.53B-$343.13M(-18.35%)Summary
- As of today (August 13, 2025), OSCR annual cash & cash equivalents is $1.53 billion, with the most recent change of -$343.13 million (-18.35%) on December 31, 2024.
- During the last 3 years, OSCR annual cash & cash equivalents has risen by +$423.19 million (+38.33%).
- OSCR annual cash & cash equivalents is now -18.35% below its all-time high of $1.87 billion, reached on December 31, 2023.
Performance
OSCR Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.60B+$362.39M(+16.20%)Summary
- As of today (August 13, 2025), OSCR quarterly cash & cash equivalents is $2.60 billion, with the most recent change of +$362.39 million (+16.20%) on June 30, 2025.
- Over the past year, OSCR quarterly cash & cash equivalents has increased by +$330.79 million (+14.58%).
- OSCR quarterly cash & cash equivalents is now at all-time high.
Performance
OSCR quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OSCR Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.4% | +14.6% |
| 3 y3 years | +38.3% | +10.0% |
| 5 y5 years | +353.6% | - |
OSCR Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.4% | +38.3% | at high | +115.5% |
| 5 y | 5-year | -18.4% | +353.6% | at high | +214.5% |
| alltime | all time | -18.4% | +353.6% | at high | +214.5% |
OSCR Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.60B(+16.2%) |
| Mar 2025 | - | $2.24B(+46.4%) |
| Dec 2024 | $1.53B(-18.3%) | $1.53B(+26.6%) |
| Sep 2024 | - | $1.21B(-46.8%) |
| Jun 2024 | - | $2.27B(+1.7%) |
| Mar 2024 | - | $2.23B(+19.3%) |
| Dec 2023 | $1.87B(+20.0%) | $1.87B(+33.6%) |
| Sep 2023 | - | $1.40B(-39.7%) |
| Jun 2023 | - | $2.32B(+10.1%) |
| Mar 2023 | - | $2.11B(+35.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.56B(+41.2%) | $1.56B(-26.2%) |
| Sep 2022 | - | $2.11B(-10.6%) |
| Jun 2022 | - | $2.36B(+14.2%) |
| Mar 2022 | - | $2.07B(+87.4%) |
| Dec 2021 | $1.10B(+33.6%) | $1.10B(+2.5%) |
| Sep 2021 | - | $1.08B(-35.6%) |
| Jun 2021 | - | $1.67B(-28.0%) |
| Mar 2021 | - | $2.32B(+180.9%) |
| Dec 2020 | $826.33M(+145.5%) | $826.33M |
| Dec 2019 | $336.64M | - |
FAQ
- What is Oscar Health, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Oscar Health, Inc.?
- What is Oscar Health, Inc. annual cash & cash equivalents year-on-year change?
- What is Oscar Health, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Oscar Health, Inc.?
- What is Oscar Health, Inc. quarterly cash & cash equivalents year-on-year change?
What is Oscar Health, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of OSCR is $1.53B
What is the all time high annual cash & cash equivalents for Oscar Health, Inc.?
Oscar Health, Inc. all-time high annual cash & cash equivalents is $1.87B
What is Oscar Health, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, OSCR annual cash & cash equivalents has changed by -$343.13M (-18.35%)
What is Oscar Health, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of OSCR is $2.60B
What is the all time high quarterly cash & cash equivalents for Oscar Health, Inc.?
Oscar Health, Inc. all-time high quarterly cash & cash equivalents is $2.60B
What is Oscar Health, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, OSCR quarterly cash & cash equivalents has changed by +$330.79M (+14.58%)